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ABSTRACT 
Objectives: To quantify health service utilization including assessment, monitoring, and treatment of 
respiratory complications of children with neuromuscular disease (NMD), identifying practice variation 
and adherence to guideline recommendations at a population level. 
 
Methods: North American population-based cohort study (2003 to 2015) of children with NMD using 
hospital diagnostic and physician billing codes within health administrative databases. 
 
Results: We identified 18,163 children with NMD. Mean (SD) age was 7.8 (5.6) years with 40% ≤ 5; 
45% were female. Most common diagnoses were cerebral palsy (50%) and spina bifida (16%); 8% had 
muscular dystrophy. From fiscal years 2003-2014, 15,600 (86%) children went to an emergency 
department on average 3.5 times every 3 years; 6,575 (36%) for respiratory reasons. 8,788 (48%) were 
admitted to hospital with 2190 (12%) for respiratory reasons and 2,451 (13%) required intensive care. 
Respiratory specialist outpatient visits occurred for 2,226 (12%) children on average 6.5 visits every 3 
years; 723 (4%) had in-hospital respiratory specialist consultation. Pulmonary function testing was 
conducted in 3,194 (18%) children on average 2.4 times every 3 years; sleep studies in 1,389 (8%).  
 
Conclusion: In this population-based study of children with NMD, healthcare utilization for respiratory 
complications was considerable. Frequency of respiratory specialist consultation, monitoring of 
respiratory function and sleep disordered breathing was variable but on average reflected professional 
society recommendations. Children with NMD are frequent ED users suggesting a need to improve 
community and social supports. We did not detect reduced access to respiratory monitoring or specialist 
consultation in adolescents transitioning to adult services.  
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INTRODUCTION 
Children with neuromuscular disorders (NMD) and their families incur significant direct and indirect 
healthcare utilization and costs including family caregiving though this varies based on the underlying 
diagnosis and disease progression 1, though data specific to respiratory complications and across 
multiple disease variants are lacking. In a US hospital administrative database study of muscular 
dystrophy (MD), hospitalization rates and duration of hospital stay were substantially higher in the MD 
group compared with children without MD 2. Similarly, Ouyang and colleagues 3 reported greater 
utilization of outpatient and in-patient services and more prescriptions by children and young adults with 
MD. Given the era of novel therapeutics 4, there is an imperative to generate better understanding of the 
current state of healthcare utilization for children with NMD to inform policy regarding allocation of 
services and funding. 
 
Progression of respiratory muscle weakness and the timing of prescription for mechanical ventilation are 
highly variable among children with NMD. For example, in children with Duchenne muscular dystrophy 
(DMD) the need for ventilatory support occurs during adolescence 5 but for children with spinal 
muscular atrophy (SMA) type 1, significant respiratory insufficiency occurs around six months6 
although onset is delayed with children receiving Nusinersen 4. Respiratory failure resulting from 
progressive respiratory muscle weakness, reduced lung volumes, impaired cough, aspiration, and 
pneumonia is the most frequent cause of death in children with NMD 7. As recommended by 
professional society guidelines 8-10, optimal assessment and monitoring of respiratory function in the 
outpatient setting enables early detection of progression of respiratory muscle weakness and prevention 
of unscheduled emergency department (ED) visits and hospital admissions. 
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We conducted a population-based cohort study using administrative databases to quantify health service 
utilization, including services used for assessment, monitoring, and treatment of respiratory 
complications associated with NMD. We hypothesized that for those children requiring specialized 
respiratory care, access to such services, and frequency of access would be variable. Secondary 
objectives were to determine: (1) factors associated with rates of ED presentation or hospital admission; 
and (2) healthcare utilization before and after transition from pediatric to adult healthcare services.  
 
METHODS 
Using health administrative databases for Ontario, Canada held at the Institute for Clinical Evaluative 
Sciences (ICES), we conducted a retrospective population-based study (2003-2015). Datasets contain 
anonymized health data for all Ontario residents, the most populous Canadian province, with a 
population of approximately 13 million 11. Costs of all medically necessary care are covered by 
universal public health insurance funded through general taxation. 
 
Data Sources and Population:  
We linked the following databases at the level of the individual through unique encoded identifiers: (1) 
Discharge Abstract Database for demographic and procedural data (including up to 24 comorbidities) 
including in-hospital death for all hospitalizations; (2) National Ambulatory Care  
Reporting System for all ED presentations; (3) Ontario Health Insurance Plan database for physician 
billings including procedures 12; (4) Assistive Devices Program (ADP) for approvals of assistive devices 
including ventilators; (5) National Rehabilitation Reporting System for inpatient rehabilitation 
programs; (6) Continuing Care Reporting System for facility based continuing (residential) care 
services; and (7) Home Care Database for home care services. To describe immigration status, we used 
the Immigration, Refugees and Citizenship Canada Permanent Resident Database. This database 
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contains individual-level demographic data on all immigrants who became permanent residents between 
1985 and 2012. Following well-established methods 13, we ascertained neighbourhood income and 
urban/rural place of residence using postal codes with linkage to Statistics Canada census data. To 
describe physician specialty, we used the Physician Database that contains information on all physicians 
practising in Ontario.   
 
For the purposes of describing healthcare utilization, we derived a cohort of children aged 0 to <18 years 
from April 1st 2003 to March 31st 2008 (5 years) using International Classification of Disease (ICD)-9, 
ICD-10 codes, and physician billing codes a priori identified as specific to NMD. Within this 5 year 
period, we sought the first instance of ICD codes identified as the ‘most responsible’ or as a secondary 
contributing diagnoses in the hospitalization database 14 indicating hospital admission with a NMD 
diagnosis. For children with NMD identified through ED presentation, we confirmed NMD diagnosis by 
looking backwards and forwards in time in the hospitalization database (1998-2014) for a NMD-related 
hospital admission. For those without ED or hospital admission, we reviewed the physician-billing 
database for NMD-related billing in these years. For children identified as having NMD using the 
physician billing code 349 (NMD diagnosis non-specific), we again searched the hospital (1998-2014) 
and ED (2000-2014) databases for a NMD specific ICD codes and examined billings from a neurologist 
or for an electromyogram to clarify diagnosis.  
 
We grouped ICD and physician billing codes into 10 categories: cerebral palsy 15; Guillain-Barre 16; 
metabolic disorders; multiple sclerosis 17; MD; myasthenia gravis 18; NMD diagnosis non-specific (i.e. 
physician billing code 349); neuropathy; spina bifida; and SMA. For modelling purposes, we further 
categorized NMD as progressive (Guillain-Barre syndrome; multiple sclerosis; myasthenia gravis; 
neuropathy; spinal muscular atrophy; metabolic disorders; muscular dystrophy; neuromuscular disorders 
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(non-specific); and non-progressive (cerebral palsy; spina bifida). We used previously validated case 
definitions to identify children who also had asthma 19. To describe co-morbidities, we determined both 
Collapsed Aggregated Diagnosis Groups (ADG) using the John Hopkin ACG® System Vers 10.0 20 and 
calculated Charlson co-morbidity score considering all hospitalizations within 2 years prior to 
identification of NMD excluding the index hospitalization. To define transition to adult healthcare 
services, we used the physician speciality database and examined the physician billing database to 
determine first contact with an adult specialist around ages 18 to 19. 
 
Outcomes 
To establish outcomes related to healthcare utilization, we followed the 2003-2008 cohort for a 
minimum of seven years to 2015. Our primary outcome was quantification of health service utilization 
for assessment, monitoring, and management of respiratory complications including respiratory related 
ED presentations and hospital admissions; consultations with a respiratory specialist (in hospital and 
ambulatory/outpatient clinic); pulmonary function testing (PFT); polysomnography (PSG); access to 
community respiratory therapists; and use of respiratory therapies in the community including oxygen, 
mechanical ventilation; and airway clearance devices.  
 
Additional public healthcare utilization data included: all cause ED presentations; all cause hospital 
admissions and duration of hospital stay; ICU admissions and duration of ICU stay; outpatient clinic 
visits to specialists other than respirology; acute care services billed by specialists other than 
pulmonology; rehabilitation; homecare services; long-term care residence. We examined factors 
associated with all cause ED presentation and hospital admission considering the following a priori 
identified potentially confounding demographic and clinical variables: NMD category 21; age; sex; 
neighbourhood income quintile; rural residence; immigration status; approval for a home ventilator; use 
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of other medical technologies (ICD codes for gastrostomy, ileostomy, colostomy, cystostomy, dialysis, 
pacemaker functional implants), comorbidities (asthma, myopathy, arrhythmias); and level of 
comorbidity using ADGs categorized as many ≥ 8 conditions or few 1-7 conditions) 20. We compared 
healthcare utilization before and after transition from pediatric to adult healthcare services.  
 
Ethical considerations  
We conducted our study according to a pre-specified protocol approved by the research ethics board at 
Sunnybrook Health Sciences Centre and according to privacy regulations of ICES. 
 
Statistical analyses 
We characterized our cohort using descriptive statistics. We used counts, proportion overall, and 
frequency over three years per child for healthcare utilization as well as mean (standard deviation (SD)), 
median (interquartile range (IQR)) of episodes of healthcare utilization. We created generalized linear 
regression models with negative binomial distribution to examine variables associated with ED 
presentation and hospital admissions controlling for variables described above. We used t tests to 
compare rates of healthcare utilization before and after transition from pediatric to adult healthcare 
services. All analyses were conducted in SAS Enterprise Guide 7.1 (SAS Institute Inc., Cary, NC, USA). 
 
RESULTS 
Health service utilization for respiratory complications 
We identified 18,163 children with NMD from 2003 to 2008. Of these, 357 (2.0%) had the first instance 
of NMD codes identified through ED presentation, 1,452 (8.0%) through hospitalization, and 16,354 
(90.0%) through physician billing. Mean age was 7.8 years, 55% were male, and 87% lived in an urban 
location. Asthma (26%) was a fairly common comorbidity (Table 1). 
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From fiscal years 2003-2014, subsequent to identification of NMD diagnosis, 6,575 (36.2%) children 
with NMD went to the ED for respiratory reasons (median [IQR] length of stay 4.6 [2.3, 10.4]) hours, 
and 2,190 (12.1%) were admitted to hospital for respiratory reasons (median [IQR] length of stay 5 [2, 
15] days). Frequency of outpatient clinic visits to a respiratory specialist was relatively stable (6.8 (28.1) 
visits in 2003-2005 and 6.5 (25.9) visits in 2012-2014 as were rates of PFTs and PSGs for children 
undergoing testing. (Table 2). Respiratory related ED visits and hospital admissions were similar for 
children with progressive and non-progressive disease but utilization of respiratory specialists, PFTs and 
PSGs by children with progressive disease was nearly double that of those with non-progressive disease. 
A publicly funded continuous positive airway pressure device was supplied to 48 (0.3%) children, home 
oxygen to 328 (1.8%), and 442 (2.4%) were supplied a publicly funded home ventilator (invasive or 
non-invasive). Only 26 (0.1%) children received a home visit from a respiratory therapist in the 
community. 
 
Other health service utilization 
From 2003-2014, subsequent to identification of NMD diagnosis, 15,578 (85.8%) children went to the 
ED (all cause) with a median [IQR] length of stay of 14 (5.9, 34.2) hours. Hospital admission occurred 
for 8,761 (48.2%) children with a median [IQR] length of stay of 7 (2, 20) days. ICU admission 
occurred for 2,446 (13.5%) (median (IQR) length of stay of 3.5 (1.2, 12.1) days. The average number of 
outpatient clinic visits to pediatric specialists other than pulmonology every 3 years increased from 12.1 
(11.9) (2003-2005) to 13.9 (16.8) (2012-2014). Only 1,993 (11.1%) were seen by a neurologist in an 
outpatient setting on average 3.5 times every 3 years. Of the cohort, 8,597 (47.3%) NMD children 
received home care services for a median (IQR) of 63 (17, 517) total hours in one year. Most common 
services were occupational therapy (2,283, 26.6%), physiotherapy (1,676, 19.5%) and case management 
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(1,326, 15.4%). Admission to a rehabilitation facility occurred for 116 (0.6%) children with a median 
(IQR) length of stay of 21 (7, 43) days. Admission to a long-term care facility occurred for 78 (0.4%) 
children. 
 
Factors associated with ED Presentation or Hospital Admission 
Our multivariable models indicate that children with diagnoses other than cerebral palsy or spina bifida 
had more ED visits and hospital admissions (P <.0001) as did the youngest age category (P<.0001) and 
poorest income quintile (P<.0001). Girls had more ED visits than boys but no difference in the 
frequency of hospital admissions. There was no association with frequency of hospital admission and 
home location, immigration status, ventilation requirement, asthma, cardiomyopathy or arrhythmia. 
Children living in rural locations, Canadian citizens, and those requiring ventilation had more frequent 
ED visits, as did children with asthma (Table 3). 
 
Health Service Utilization Before and After Transition to Adult Healthcare 
Of the 18,163 children that formed our 2003-2008 cohort, 2,451 (13%) transitioned from pediatric to 
adult healthcare services. In the 3 years before and after transition we found an increase in all-cause ED 
visits (mean (SD) 3.8 (5.0) to 4.3 (6.4), P=0.02)) and increased length of ED visit (13.4 (24.9) versus 
17.8 (35.9) hours, P<.0001). Length of respiratory related ED visits also increased (P=0.003). 
Conversely, length of all cause hospital admissions reduced from 17.0 (35.9) to 12.4 (28.7) days 
(P=0.03). There were no differences in frequency of pulmonologist consults, PFTs, or PSGs. We found 
no differences in the frequency or duration of health service utilization in the one year before and after 
transition (Table 4).   
 
DISCUSSION 
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In this retrospective population-based study of children with NMD, we detected a substantial burden of 
healthcare utilization for respiratory reasons with over one third visiting the ED (42% of all ED visits, 
on average twice every 3 years, and 12% requiring hospital admission (24% of all hospital admissions) 
for respiratory related causes. However, only 4% of our cohort was seen by a respiratory specialist in 
hospital, and 12% was seen by a respiratory specialist in an outpatient setting. Children under 
respiratory specialist care were seen frequently (average every 6 months), however substantial variation 
was noted. Only 2.4% children received mechanical ventilation (either invasive or non-invasive). Other 
healthcare utilization was common among the cohort, particularly ED visits with at least one visit a year 
on average and some children attending the ED multiple times a year. Following transition from 
pediatric to adult services, there was no change in utilization of respiratory related healthcare services or 
hospitalization rates.   
 
In our cohort, although the overall proportion of children receiving specialist respiratory care was 
relatively low, children with diagnoses other than cerebral palsy and spina bifida had higher rates of 
respiratory specialist consultation and disease monitoring through PFTs and PSGs.  For those children 
receiving respiratory specialist care, the frequency of outpatient clinic visits and lung function 
monitoring, was on average consistent with current guideline recommendations 8-10, however as 
hypothesized we found substantial variability in terms of the frequency of visits and monitoring as 
demonstrated by the standard deviations reported in Table 2. This is likely attributable to a combination 
of referral patterns, access, and disease progression, factors difficult to determine from health 
administrative databases. Current guidelines recommend 6 monthly out-patient follow-up and PFTs 
annually in children with progressive disease. PSGs were conducted 1.4 times in three years, although 
again with substantial variability, which is slightly less frequent than the recommended annual 
assessment 8, and again likely attributable to a combination of referral patterns, access, but also 
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Canadian pediatric sleep laboratory capacity 22. Respiratory out-patient follow-up was more frequent 
than we have previously reported for adults with NMD (average of 4 visits every 3 years) 23, however 
we found similar frequency of PFTs and PSGs. 
 
Our data indicate children with NMD are frequent users of the ED with only 15% never visiting the ED, 
and more than one visit each year on average for those children that did. As reported in studies of ED 
visits for other conditions, younger age was associated with recurrent ED visits 24, 25. Recurrent ED use 
may reflect suboptimal access to community healthcare and supports 26, lack of access to specialty care, 
lack of care integration, lack of respite, and inexperience of general practitioners with this disease 27, 28. 
From our data, we can conclude that strategies are needed urgently to improve community and social 
supports for children with NMD and their families. 
 
This study represents one of the largest cohorts reporting healthcare utilization of adolescents with NMD 
before and after transition from pediatric to adult healthcare services. The absence of a reduction in 
respiratory monitoring or specialist consultation suggests no change in access to, or accessibility of, 
these services. We did find an increase in all-cause, but not respiratory related ED presentations, and an 
increase in ED visit length likely reflective of prolonged ED wait times for adults in Canada 29. Cohen 
and colleagues also noted stable patterns of health care utilization after transfer from pediatric to adult 
care in a Canadian population-based study of youth with chronic conditions 30. Our findings differ from 
studies in other countries of adolescents with complex medical conditions, including those requiring 
mechanical ventilation, that report increased healthcare drop-out and poor treatment adherence resulting 
in increased use of acute healthcare services 31-34. Identification of effective transition models is of 
particular importance given further increases in life expectancy as more novel therapeutics become 
available. 
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Limitations of our study include: potential for misclassification, particularly using physician-billing 
codes to identify NMD and the inability to further classify the type of NMD in those children identified 
using physician billing code 349.  Oskoui and colleagues reported classification errors using ICD coding 
to estimate the prevalence of cerebral palsy 35. Second, limitations of health administrative database 
coding prevented more disease specific description of healthcare utilisation i.e., Duchenne muscular 
dystrophy, the most common muscular dystrophy, as well as an estimation of either disease severity or 
disease progression on an individual patient level or within disease categories. Third, we were unable to 
determine ambulatory status to further explore compliance with disease progression specific guideline 
recommendations 9, 10 or stratify results by disease stage. Fourth, we were unable to assess use of airway 
clearance strategies as these devices were only publicly funded, and therefore detectable in the ADP 
database, from 2014 onwards.  
 
CONCLUSION 
Healthcare utilization for respiratory complications comprised 42% and 24% of all ED visits and 
hospital admissions.. Frequency of respiratory specialist consultation, monitoring of respiratory function 
and sleep disordered breathing was variable but on average reflected the recommendations of 
professional societies. Children with NMD are frequent users of the ED suggesting strategies are needed 
urgently to improve community and social supports Adolescents experiencing transition from paediatric 
to adult healthcare services did not experience a reduction in access to respiratory monitoring or 
specialist consultations.      
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Table 1 Cohort baseline characteristics 
  Cerebral 
palsy 
Guillian 
Barre  
Metabolic 
Disorders 
Multiple 
sclerosis 
Muscular 
dystrophy 
Myasthenia 
gravis   
NMD non‐
specific  
Neuropathy  Spina bifida   SMA   
Total   9,107  97 245 837 1,504 878 2,508 48 2,910 29
Age (years)                           
mean (SD)  7 (5.3)  9 (5.6) < 6 11 (5.0) 8 (5.4) 10 (6) 9 (6.0) 12 (4.7) 7 (5.7) 6 (5.6)
Sex                           
Female  3,841 (42)  36 (37)  108 (44)  445 (53)  538 (36)  435 (50)  1183 (47)  23 (48)  1469 (50)  16 (55) 
Male  5,266 (58)  61 (63)  137 (56)  392 (47)  966 (64)  443 (50)  1325 (53)  25 (52)  1441 (50)  13 (45) 
Neighbourhood Income Quintilea                   
1 (poorest/lowest)  1,975 (22)  10 (10)  63 (26.)  149 (18)  290 (19)  176 (20)  492 (29)  7 (15)  542 (19)  < 6 
2  1,785 (20)  25 (26) 49 (20) 151 (18) 311 (21) 188 (21) 472 (19) 11 (23) 533 (18) 6 (21)
3  1,780 (20)  26 (27) 52 (21) 180 (22) 301 (20) 170 (19) 493 (20) 10 (21) 620 (21) < 6
4  1,857 (20)  21 (22) 42 (17) 178 (21) 313 (21) 193 (22) 522 (21) < 6 632 (22) 6 (21)
5 (richest/highest)  1,679 (19)  15 (15)  36 (15)  174 (21)  278 (19)  149 (17)  525 (21)  15 (31)  571 (20)  7 (25) 
Rural Residenceb   
No  7,925 (87)  88 (91)  222 (91)  758 (91)  1,266 (84)  759 (86)  2,229 (89)  39 (81)  2,480 (85)  22 (76) 
Yes  1,177 (13)  9 (9)  22 (9)  79 (9)  236 (16)  119 (14)  278 (11)  9 (19)  427 (15)  7 (24) 
Immigration Statusc                       
Citizen  8,590 (94)  91 (94) 237 (95) 777 (93) 1,406 (93) 812 (92) 2,363 (94) 44 (92) 2,813 (97) 26 (90)
Immigrationd  383 (4)  < 6 < 6 48 (6) 71 (5) 47 (5) 104 (4) < 6 73 (3) < 6
Refugee  133 (1)  ‐ < 6 12 (1) 27 (2) 18 (2) 39 (2) ‐ 23 (1) < 6
Comorbidity                         
Asthma   2563 (28)  24 (25)  52 (21)  220 (26)  331 (22)  218 (25)  672 (27)  15 (31)  551 (19)  12 (41) 
Charlson Comorbidity Index (CCI)                       
0  2726 (75)  84 (93)  201 (87)  200 (88)  427 (89)  211 (90)  824 (79)  37 (88)  1257 (91)  24 (89) 
1 (1 to 3)  901 (25)  6 (7)  31 (13)  27 (12)  47 (10)  23 (10)  204 (20)  < 6 (12)  113 (8)  < 6 
2 (≥4)  22 (1)  ‐ ‐ ‐ 8 (2) < 6 (0) 10 (1) ‐ < 6 ‐
Note: some percentages may not sum to 100 due to rounding. NMD: neuromuscular disease (other); SMA: spinal muscular atrophy; SD: standard deviation 
a Unable to establish for 69 children; b Unable to establish for 12 children; c Unable to establish for 6 children; d Immigrant is defined as resident within 
Ontario as holding either Canadian permanent residency status or a work, student, or other form of visa; e Charlson comorbidity index calculated for 
those children admitted to hospital considering all hospitalizations within 2 years prior to the index event  (7,397 children). 
Table 2 Health service utilization after NMD diagnosis 
Health service 
N = 18,163 children 
n (%) of 
children 
Mean (SD) number of visits per  three fiscal years per 
childa 
2003‐ 
2005 
2006‐ 
2008  2009‐2011  2012‐2014 
Respiratory related ED visits    6,575 (36.2) 1.9 (1.8) 1.9 (1.8)  1.8 (1.7)  1.7 (1.5)
Respiratory related hospital admission   2,190 (12.1) 1.7 (1.4) 1.7 (1.4)  1.8 (1.6)  1.7 (1.6)
Respirology outpatient clinic  2,226 (12.3) 6.8 (28.1) 8.6 (32.3)  7.1 (32.3)  6.5 (25.9)
Hospital respirology consult  723 (4.0) 3.4 (5.4) 5.0 (19.7)  4.8 (17.3)  6.0 (17.9)
Pulmonary function tests  3,194 (17.6) 2.1 (3.1) 2.3 (2.6)  2.4 (3.7)  2.4 (2.7)
Sleep studies  1,389 (7.6) 1.6 (1.0) 1.7 (1.1)  1.5 (0.8)  1.4 (0.7)
Outpatient clinic (non‐respirology)  18,029 (99.3) 12.2 (12.2) 13.6 (14.7)  14.7 (17.3)  14 (16.8)
Hospital consult (non‐respirology)  8,817 (48.5) 5.6 (9.7) 6.3 (13)  6.8 (17.7)  7.3 (15.2)
All cause ED visits   15,600 (85.9) 3.3 (3.9) 3.5 (4.2)  3.6 (4.6)  3.5 (4.9)
All cause hospital admission   8,788 (48.4) 2.3 (2.6) 2.3 (2.6)  2.3 (2.7)  2.1 (2.4)
ICU admission  2,451 (13.5) 1.5 (1.2) 1.5 (1.1)  1.5 (1.2)  1.7 (1.4)
a  Calculated for individuals in the cohort requiring these services. 
ED: Emergency department; ICU: intensive care unit; SD: standard deviation. 
   
 
Table 3 Variables associated with the number of hospital admissions and ED visits after NMD diagnosis 
  Hospital admissions  ED visits 
Variables  Estimate 95% CI  P value  Estimate  95% CI  P value 
Neuromuscular disease (reference = cerebral palsy or spina bifida)         
Other neuromuscular diseases  0.38  0.25  0.52  <.0001  0.10  0.06  0.14  <.0001 
Age (reference = age 0‐5 years)         
6‐10 years  ‐0.74  ‐0.91  ‐0.58  <.0001  ‐0.32  ‐0.37  ‐0.27  <.0001 
11‐17 years  ‐0.81  ‐0.96 ‐0.66 <.0001 ‐0.18  ‐0.22  ‐0.13 <.0001
Female  0.09  ‐0.03 0.21 0.15 0.07  0.03  0.11 0.0002
Neighbourhood income quintile (reference = 1 poorest/lowest)        
Income quintile 2  ‐0.39  ‐0.58  ‐0.20  <.0001  ‐0.13  ‐0.19  ‐0.07  <.0001 
Income quintile 3  ‐0.36  ‐0.55  ‐0.17  0.0002  ‐0.21  ‐0.27  ‐0.15  <.0001 
Income quintile 4  ‐0.43  ‐0.62  ‐0.24  <.0001  ‐0.28  ‐0.34  ‐0.22  <.0001 
Income quintile 5  ‐0.40  ‐0.60  ‐0.21  <.0001  ‐0.30  ‐0.36  ‐0.24  <.0001 
Rural residence  ‐0.02  ‐0.21  0.16  0.81  0.57  0.52  0.62  <.0001 
Immigration status (reference = citizen)         
Immigrant  0.12  ‐0.20 0.44 0.47 ‐0.40  ‐0.49  ‐0.30 <.0001
Refugee  0.43  ‐0.08 0.93 0.10 ‐0.22  ‐0.38  ‐0.06 0.007
Ventilation status (reference = none)         
Invasive ventilation  0.76  ‐0.19  1.72  0.12  0.67  0.36  0.98  <.0001 
Non‐invasive ventilation  ‐0.02  ‐0.69  0.66  0.96  0.39  0.19  0.60  0.0001 
Use of other medical technologya  1.61  0.86  2.37  <.0001  0.35  0.11  0.60  0.005 
Comorbidities     
Asthma  0.07  ‐0.08 0.22 0.35 0.20  0.15  0.24 <.0001
Cardiomyopathy  ‐0.65  ‐2.63 1.34 0.52 ‐0.20  ‐0.84  0.43 0.53
Arrhythmias  0.70  ‐0.65 2.05 0.31 0.28  ‐0.16  0.71 0.21
Collapsed Aggregated Diagnosis Group (reference  = few 1‐7)         
Many (8‐16)  0.86  0.72  0.99  <.0001  0.59  0.55  0.64  <.0001 
None  0.66  0.33  0.99  0.0001  0.11  0.00  0.21  0.04 
a  individuals requiring any of the following: gastrostomy, ileostomy, colostomy, cystostomy, or pacemaker and 
functional implants.
Table 4 Healthcare utilization before after transition from paediatric to adult healthcare services 
N = 2,451  n (%)a  Overall 
priorb 
Overall 
afterc 
P value  n (%)  1 year prior  1 year after  P value 
Respiratory related ED visits    537 (21.9)  1.6 (1.1)  1.5 (1.0)  0.44  266 (10.9)  1.3 (0.8)  1.3 (0.6)  0.79 
Length of ED visit , hrs  ‐  3.7 (3.5)  5.4 (9.8)  0.003  ‐  3.5 (3.4)  3.4 (4.4)  0.91 
Respiratory related hospital admission   54 (2.2)  1.6 (1.1)  1.4 (0.7)  0.87  19 (0.8)  1.3 (0.8)  1.3 (0.6)  0.78 
Length of hospital stay, days  ‐  8.7 (13.1)  7.3 (9.1)  0.65  ‐  3.5 (3.4)  3.4 (4.4)  0.91 
Respirology outpatient clinic   278 (11.3)  3.2 (8.0)  5.2 (17.9)  0.18  123 (5)  3.9 (10.1)  4.3 (10.1)  0.84 
Hospital respirology consult  41 (1.7) 2.0 (2.3) 3.8 (4.7) 0.07 16 (0.7) 1.7 (1.5) 3.6 (4.7) 0.21 
Pulmonary function tests  386 (15.7) 2.2 (3.9) 2.3 (3.9) 0.86 189 (7.7) 1.5 (1.4) 1.7 (2.5) 0.65 
Sleep studies  113 (4.6) 1.5 (0.7) 1.5 (0.9) 0.74 66 (2.7) 1.4 (0.7) 1.4 (0.7) 0.77 
All cause ED visits   2,004 (81.8)  3.8 (5.0)  4.3 (6.4)  0.02  1,343 (54.8)  2.4 (2.4)  2.5 (2.7)  0.63 
Length of ED visit, hrs  ‐  13.4 (24.9)  17.8 (35.9)  <.0001  ‐  8.5 (12.3)  9.7 (16.6)  0.09 
All cause hospital admission   804 (32.8)  2.0 (2.4)  1.8 (1.9)  0.41  386 (15.7)  1.4 (1.1)  1.4 (1.0)  0.88 
Length of hospital stay, days  ‐  17.0 (35.9)  12.4 (28.7)  0.03  ‐  12.1 (29.8)  9.1 (20.9)  0.22 
ICU admission  186 (7.6)  1.7 (1.7)  1.6 (1.3)  0.71  71 (2.9)  1.6 (1.4)  1.3 (0.6)  0.24 
Length of ICU admission, days  ‐  8.1 (13.8)  9.0 (12.2)  0.84  ‐  9.3 (17.3)  6.5 (8.9)  0.38 
All values are medians (interquartile ranges). 
a  n (%) of individuals that utilized these healthcare services in both the years preceding and the years following transition from paediatric to adult 
services. 
b  calculated for the 3 years prior to transition. 
c  calculated for  3 years after transition. 
 
